Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Surrozen (NasdaqCM:SRZN) with a Buy ...

Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Knightscope (NasdaqCM:KSCP) with a Buy ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...

In a report released today, Kevin Dede from H.C. Wainwright maintained a Buy rating on Neptune Digital Assets (NDA – Research Report), with a ...

Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They currently have a ...

Research analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of GH Research in a report released on Monday, January 27th. HC Wainwright analyst P. Trucchio ...

Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new ...

The identity of these investors remains unknown, but such a substantial move in NNE usually suggests something big is about ...

Northern Dynasty Minerals Ltd (NAK) stock saw a decline, ending the day at $0.63 which represents a decrease of $-0.01 or -1.56% from the prior close of $0.64. The stock opened at $0.63 and touched a ...

Inc. (Nasdaq: ELTX, “” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where CleanSpark, Inc. (NASDAQ:CLSK) stands against the other stocks.